2024-06-19 REL RCSB RCSB RCSB 2022-12-27 2023-08-09 2023-08-09 2024-06-19 National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) U01 AI136680 United States National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) R01 AI146017 United States National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) U54 AI170855 United States National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) R35 GM132090 United States National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) GM148049 United States Shan ZL Passos DO Strutzenberg TS Li M Lyumkis D Integrase, Nucleoprotein complex, Inhibitor, Drug resistance, VIRAL PROTEIN-DNA-INHIBITOR complex Li M Oliveira Passos D Shan Z Smith SJ Sun Q Biswas A Choudhuri I Strutzenberg TS Haldane A Deng N Li Z Zhao XZ Briganti L Kvaratskhelia M Burke Jr TR Levy RM Hughes SH Craigie R Lyumkis D Sci Adv US 9 eadg5953 eadg5953 2023 37478179 doi:10.1126/sciadv.adg5953 2375-2548 EMD-29307 other EM volume 8fnn FULLOVERLAP E138K/G140A/Q148K HIV-1 intasome bound to dolutegravir E138K/G140A/Q148K HIV-1 intasome bound to dolutegravir 0 1 2 3 Human immunodeficiency virus 1 0.5 Lamina-associated polypeptide 2, isoform alpha,Integrase chimera Human immunodeficiency virus 1 0.0399135 8 Escherichia coli LEVO GSHMPKRGRPAATEVKIPKPRGRPPLPAGTNSKGPPDFSSDEEREPTPVLGSGAAAAGQSRAAVGRKATKKTDGGGFLDG IDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYI EAEVIPAETGQETAYFLLKLAGRWPVKTVHTDNGSNFTSTTVKAACWWAGIKQKFAIPYNPQSKGVIESMNKELKKIIGQ VRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPVWKGPAKLLWK GEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED P42166 P12497 2.7.7.- DNA (27-MER) Human immunodeficiency virus 1 0.008188270999999999 2 (DA)(DC)(DT)(DG)(DC)(DT)(DA)(DG)(DA)(DG)(DA)(DT)(DT)(DT)(DT)(DC)(DC)(DC)(DG)(DC) (DC)(DC)(DA)(DC)(DG)(DC)(DT) DNA DNA (25-MER) Human immunodeficiency virus 1 0.0077730229999999996 2 (DA)(DG)(DC)(DG)(DT)(DG)(DG)(DG)(DC)(DG)(DG)(DG)(DA)(DA)(DA)(DA)(DT)(DC)(DT)(DC) (DT)(DA)(DG)(DC)(DA) DNA MAGNESIUM ION 2.4305e-05 4 MG ZINC ION 6.5409e-05 2 ZN (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide 0.000419379 2 DLU water 1.8015e-05 593 HOH singleParticle particle 7.5 20.0 C8H18N2O4S HEPES 25.0 C3H8O3 glycerol 50.0 C12H19NO3S NDSB-256 5.0 HOCH2CH2SH Beta-mercaptoethanol 4.0 ZnCl2 Zinc chloride 100.0 NaCl Sodium chloride 5.0 CaCl2 Calcium chloride 50.0 C20H19F2N3O5 Dolutegravir Quantifoil GOLD GOLD HOLEY ETHANE FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 2.7 1.5 3.0 58139.0 FEI TITAN KRIOS AUTOGRID HOLDER NITROGEN GIF Bioquantum 20 GATAN K3 BIOQUANTUM (6k x 4k) COUNTING 30.0 1 677866

Published structure EMD-21151

C2 2.7 FSC 0.143 CUT-OFF cryoSPARC 3 99619 MAXIMUM LIKELIHOOD MAXIMUM LIKELIHOOD FLEXIBLE FIT REAL emd_29319_msk_1.map emd_29319_additional_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 384 384 384 0 0 0 384 384 384 330.24 330.24 330.24 90.0 90.0 90.0 X Y Z -0.28761768 1.1593696 0.0015858981 0.026327014 0.85999995 0.85999995 0.85999995 AUTHOR ::::EMDATABANK.org::::EMD-29319:::: Unsharpened map of E138K/G140A/Q148K HIV-1 intasome with drug Dolutegravir emd_29319_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 384 384 384 0 0 0 384 384 384 330.24 330.24 330.24 90.0 90.0 90.0 X Y Z -0.37588656 1.2054057 0.0016199908 0.035968035 0.85999995 0.85999995 0.85999995 AUTHOR ::::EMDATABANK.org::::EMD-29319:::: Half map1 of E138K/G140A/Q148K HIV-1 intasome with drug Dolutegravir emd_29319_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 384 384 384 0 0 0 384 384 384 330.24 330.24 330.24 90.0 90.0 90.0 X Y Z -0.4297569 1.3054736 0.0016230994 0.035953715 0.85999995 0.85999995 0.85999995 AUTHOR ::::EMDATABANK.org::::EMD-29319:::: Half map2 of E138K/G140A/Q148K HIV-1 intasome with drug Dolutegravir